Robert A. Doody joined Prelude Therapeutics in 2024 at Senior Vice President, Investor Relations.  He has over 20 years of communications experience in pharma and biotech across numerous therapeutic sectors.  Prior to joining Prelude, Mr. Doody was Senior Vice President of Investor Relations at Aclaris Therapeutics.  Previous to that, Mr. Doody served as the senior Investor Relations leader at Provention Bio, Idera Pharmaceuticals, and ViroPharma Incorporated. Additionally, Mr. Doody served honorably in the United States Navy. He earned his communications degree from Rowan University.